Evidence map›Paper›PMID 32931287›Full record

ArticleJournal of proteome research2020

Research on the Human Proteome Reaches a Major Milestone: >90% of Predicted Human Proteins Now Credibly Detected, According to the HUPO Human Proteome Project.

Gilbert S Omenn, Lydie Lane, Christopher M Overall, Ileana M Cristea, Fernando J Corrales, Cecilia Lindskog, Young-Ki Paik, Jennifer E Van Eyk, Siqi Liu, Stephen R Pennington and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. SpliceProt 2.0: A Sequence Repository of Human, Mouse, and Rat Proteoforms.International journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Advances and Utility of the Human Plasma Proteome.Journal of proteome research · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. A Multi-Omics Study of Human Testis and Epididymis.Molecules (Basel, Switzerland) · 2021
    Article
  19. Review
  20. Proteome-based pathology: the next frontier in precision medicine.Expert review of precision medicine and drug development · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 9 countries.

Gilbert S OmennUniversity of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-8976-6074
Lydie LaneCALIPHO Group, SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.ORCID 0000-0002-9818-3030
Christopher M OverallUniversity of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Ileana M CristeaPrinceton University, Princeton, New Jersey 08544, United States.ORCID 0000-0002-6533-2458
Fernando J CorralesCentro Nacional de Biotecnologia, 28049 Madrid, Spain.ORCID 0000-0002-0231-5159
Cecilia LindskogUppsala University, 752 36 Uppsala, Sweden.ORCID 0000-0001-5611-1015
Young-Ki PaikYonsei Proteome Research Center, Seoul 03722, Korea.ORCID 0000-0002-8146-1751
Jennifer E Van EykCedars Sinai, Los Angeles, California 90048, United States.ORCID 0000-0001-9050-148X
Siqi LiuBGI Group, Shenzhen 518083, China.ORCID 0000-0001-9744-3681
Stephen R PenningtonUniversity College Dublin, Dublin 4, Ireland.
Michael P SnyderStanford University, Stanford, California 94305, United States.
Mark S BakerMacquarie University, Macquarie Park, NSW 2109, Australia.ORCID 0000-0001-5858-4035
Nuno BandeiraUniversity of California, San Diego, La Jolla, California 92093, United States.ORCID 0000-0001-8385-3655
Ruedi AebersoldETH-Zurich and University of Zurich, 8092 Zurich, Switzerland.
Robert L MoritzInstitute for Systems Biology, Seattle, Washington 98109, United States.ORCID 0000-0002-3216-9447
Eric W DeutschInstitute for Systems Biology, Seattle, Washington 98109, United States.ORCID 0000-0001-8732-0928
Institute for Systems Biology · USBGI Group (China) · CNCedars-Sinai Medical Center · USCentro Nacional de Biotecnología · ESMacquarie University · AUPrinceton University · USSIB Swiss Institute of Bioinformatics · CHStanford University · USUniversity College Dublin · IEUniversity of British Columbia · CAUniversity of California San Diego · USUniversity of Michigan · USUniversity of Zurich · CHUppsala University · SEYonsei Proteome Research Center · KR

Funding

Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI NICHOLAS Joseph SCHORK · 2004 to 2026
$102.6M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Genomic and Proteomic Architecture of AtherosclerosisR01HL111362 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HERRINGTON, DAVID MCLEOD · 2012 to 2021
$17.2M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
University of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1M
Mechanisms mediating immune response upon sensing of nuclear viral DNAR01GM114141 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 2015 to 2023
$2.6M
Advancing data and metadata standards for proteomics mass spectraR24GM127667 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC · 2017 to 2019
$1.2M
NCI NIH HHS U24 CA210967NHLBI NIH HHS R01 HL111362NIA NIH HHS U19 AG023122NIEHS NIH HHS P30 ES017885NIGMS NIH HHS R01 GM087221NIGMS NIH HHS R01 GM114141NIGMS NIH HHS R24 GM127667
6 · The paper itself

Abstract

According to the 2020 Metrics of the HUPO Human Proteome Project (HPP), expression has now been detected at the protein level for >90% of the 19 773 predicted proteins coded in the human genome. The HPP annually reports on progress made throughout the world toward credibly identifying and characterizing the complete human protein parts list and promoting proteomics as an integral part of multiomics studies in medicine and the life sciences. NeXtProt release 2020-01 classified 17 874 proteins as PE1, having strong protein-level evidence, up 180 from 17 694 one year earlier. These represent 90.4% of the 19 773 predicted coding genes (all PE1,2,3,4 proteins in neXtProt). Conversely, the number of neXtProt PE2,3,4 proteins, termed the "missing proteins" (MPs), was reduced by 230 from 2129 to 1899 since the neXtProt 2019-01 release. PeptideAtlas is the primary source of uniform reanalysis of raw mass spectrometry data for neXtProt, supplemented this year with extensive data from MassIVE. PeptideAtlas 2020-01 added 362 canonical proteins between 2019 and 2020 and MassIVE contributed 84 more, many of which converted PE1 entries based on non-MS evidence to the MS-based subgroup. The 19 Biology and Disease-driven B/D-HPP teams continue to pursue the identification of driver proteins that underlie disease states, the characterization of regulatory mechanisms controlling the functions of these proteins, their proteoforms, and their interactions, and the progression of transitions from correlation to coexpression to causal networks after system perturbations. And the Human Protein Atlas published Blood, Brain, and Metabolic Atlases.

Indexed as

ProteomeProteomicsDatabases, ProteinGenome, HumanHumansMass SpectrometryProteomeBiology and Disease-HPP (B/D-HPP)Chromosome-Centric HPP (C-HPP)Human Protein AtlasHuman Proteome Project (HPP)Mass Spectrometry Interactive Virtual Environment (MassIVE)missing proteins (MPs)neXtProt protein existence (PE) metricsnon-MS PE1 proteinsPeptideAtlasuncharacterized protein existence 1 (uPE1)

Identifiers

PMID32931287
PMCPMC7718309
OpenAlexW3087085648

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.